Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cronin Group was a biotechnology and technology company focused on the digitization of chemical synthesis and drug discovery. Founded by Professor Lee Cronin of the University of Glasgow, the company developed the "Digital Chemist" platform, which aimed to automate the discovery and manufacture of complex molecules. The core technology, often referred to as the "Chemputer," sought to transform chemical recipes into digital code that could be executed by robotic systems. In 2018, the company acquired DeepMatter and subsequently changed its name to DeepMatter Group PLC to focus on its cloud-based chemical data platform. While the original Cronin Group entity evolved, its foundational work in autonomous chemistry continues to influence the digital transformation of the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cronin.